Contact Us
Thank you for choosing Dermatology Times as your trusted resource. Together, we are advancing the science of skin health and enhancing the lives of patients worldwide. We value you and your feedback. Whether you have questions, suggestions, or topics you would like us to cover, we encourage you to reach out to us via email at
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5
